- Open Access
Molecular and histological effects of MR-guided pulsed focused ultrasound to the rat heart
Journal of Translational Medicine volume 15, Article number: 252 (2017)
Image-guided high intensity focused ultrasound has been used as an extracorporeal cardiac pacing tool and to enhance homing of stem cells to targeted tissues. However, molecular changes in the myocardium after sonication have not been widely investigated. Magnetic-resonance (MR)-guided pulsed focused ultrasound (pFUS) was targeted to the rat myocardium over a range of pressures and the microenvironmental and histological effects were evaluated over time.
Eight-to-ten-week-old Sprague–Dawley rats received T2-weighted MR images to target pFUS to the left ventricular and septum without cardiac or respiratory gating. Rats were sonicated through the thoracic wall at peak negative pressures (PNP) from 1 to 8 MPa at a center frequency of 1 MHz, 10 ms pulse duration and 1 Hz pulse repetition frequency for 100 pulses per focal target. Following pFUS, myocardium was harvested over 24 h and subjected to imaging, proteomic, and histological measurements.
pFUS to the myocardium increased expression of cytokines, chemokines, and trophic factors characterized by an initial increase in tumor necrosis factor (TNF)-α followed by increases in pro- and anti-inflammatory factors that returned to baseline by 24 h. Immediately after pFUS, there was a transient (< 1 h) increase in N-terminal pro b-type natriuretic peptide (NT-proBNP) without elevation of other cardiac injury markers. A relationship between PNP and expression of TNF-α and NT-proBNP was observed with significant changes (p < 0.05 ANOVA) ≥ 4 MPa compared to untreated controls. Contrast-enhanced ex vivo T1-weighted MRI revealed vascular leakage in sonicated myocardium that was accompanied by the presence of albumin upon immunohistochemistry. Histology revealed infiltration of neutrophils and macrophages without morphological myofibril changes in sonicated tissue accompanied by pulmonary hemorrhage at PNP > 4 MPa.
MR-guided pFUS to myocardium induced transient proteomic and histological changes. The temporal proteomic changes in the myocardium indicate a short-lived sterile inflammatory response consistent with ischemia or contusion. Further study of myocardial function and strain is needed to determine if pFUS could be developed as an experimental model of cardiac injury and chest trauma.
Cardiovascular disease (CVD) represents a class of pathology that is considered one of the most serious public health threats. The prevalence is approximately 7 million people in the US and clinical manifestations include sinus node dysfunction, complete heart block, stroke, heart failure, cardiomyopathy and arrhythmia . CVD can result in high blood pressure, myocardial infarction, stroke or sudden death if left untreated [2,3,4]. Numerous treatment options for CVD include lifestyle changes, pharmacological therapy, and surgery that have variable clinical outcomes depending on the severity of disease [5, 6]. The implantation of cardiac pacemakers, a common clinical option for treating arrhythmias, can result in improved cardiac function and quality of life . However, this procedure is associated with some morbidity due to infection and the surgical procedure .
Image-guided high-intensity focused ultrasound (HIFU), using ultrasound (US) or magnetic resonance imaging (MRI) guidance, is a noninvasive technique that sonicates targeted regions in the body. It has been clinically approved to treat uterine fibroids, prostate cancer, and essential tremor [9,10,11]. Current clinical HIFU therapies apply continuous US to generate ablative temperatures within treatment volumes [12,13,14]. Alternatively, pulsed focused ultrasound (pFUS), that deposits primarily mechanical rather than thermal energy is experimental, but promising for several applications. It has been demonstrated to induce local molecular changes that increase tropism of systemically-infused stem cell therapies [15,16,17,18,19]. Mechanical forces from pFUS can be modulated by adjusting numerous US parameters such as pulse length, duty cycle, and peak negative pressure (PNP). The potential for pFUS as a noninvasive pacing tool has been superficially explored with promising results [20,21,22,23,24,25]. Previous reports have superficially examined proteomic and histological changes in ischemic myocardium following ultrasound-mediated microbubble destruction as a means to attract therapeutic stem cells [26,27,28], but systematic evaluation of pFUS effects on myocardial tissue and the possibility of coincident pulmonary contusion [29, 30] is virtually nonexistent.
This study therefore evaluated the mechanical non-thermal effects of MR-guided pFUS to the myocardium as a function of PNP to understand proteomic and histological changes over time. We observed that a transient sterile inflammatory response (SIR) in the treated myocardium that was associated with cardiac injury marker activation, inflammatory cell infiltration, and vascular leakage returning to baseline by 24 h post-pFUS.
All animal studies were approved by the Animal Care and Use Committee at the NIH Clinical Center, and experiments were performed in accordance with the National Research Council’s Guide for the Care and Use of Laboratory . Female Sprague–Dawley rats (8–10 weeks of age, 230.2 ± 9.7 g; Charles River Laboratories, Wilmington, MA) were given free access to food and water. Hair on the chest was removed with depilatory cream prior to pFUS treatment. pFUS attenuation through the chest wall was determined by measuring relative transducer output with a hydrophone (HGL-1000, ONDA Corporation, Sunnyvale, CA) in degassed H2O. Measurements were recorded with and without excised rat chests (n = 3) placed in front of the hydrophone.
MR-guided pFUS and MRI
Rats (n = 85) were anesthetized with 1.5% isoflurane in 100% O2 and placed in the left lateral recumbent position on a preclinical MR-compatible image-guided focused ultrasound system (RK-100, FUS instruments, Ontario, Canada) with the left side of the chest submerged in degassed H2O maintained at 37 °C. Hearts were imaged without respiratory or cardiac gating using a radiofrequency receive coil on a 3T clinical MR scanner (Achieva, Philips Healthcare, USA) (Fig. 1a–c). Targeting MRI used multislice fast field echo (FFE) sequences with repetition time (TR) = 8.9 ms, echo time (TE) = 4.5 ms, flip angle (FA) = 45° and a slice thickness of 1 mm with an in-plane resolution of 0.14 × 0.14 mm2. pFUS was targeted toward the left ventricle (LV) and septum. The approximate LV length was 6.5 mm and the thickness of LV septum was 1.7 mm. The MRI slice thickness was similar to pFUS focal dimensions (diameter = 1.2 mm; length = 6 mm). pFUS was performed at a center frequency of 1 MHz using a transducer with a focal length of 6 cm and an electro-acoustic conversion efficiency of 75.9%. Sonications were performed at 1, 3, 4, 6, and 8 MPa PNP. The corresponding spatial averaged and temporal peak intensities (ISATP) were: (in W/cm2) 52 at 1 MPa, 472 at 3 MPa, 839 at 4 MPa, 1886 at 6 MPa, and 3355 at 8 MPa. Intensity values were confirmed by radiation force balance measurements. Using targeting images, approximately 20 foci in the LV and septum were treated with pFUS using the following US parameters: pulse length, 10 ms; duty cycle, < 1%; 100 pulses/site (Fig. 1d). Prior to pFUS, animals were given intravenous infusions of gadofosveset (200 µL/kg) (Lantheus Medical Imaging Inc., MA). Cardiac or respiratory gating was not used during sonication. At various times after pFUS, rats were euthanized and perfused with 4% paraformaldehyde (PFA) in 1× phosphate-buffered saline (PBS). Ex vivo post contrast T1-weighted (T1w) MRI was performed using a radiofrequency quadrature coil (Doty Scientific In., Columbia, SC) on a 7T MR microimaging system (Bruker Corp., Billerica, MA) with the following parameters: TR, 200 ms; TE, 8 ms; and resolution, 100 µm3. MR images were 3D reconstructed using Osirix software (Pixmeo, Geneva, Switzerland). The images were normalized to the mean signal intensity of each heart for a group-wise comparison. To calculate the fold changes of MR contrast following pFUS, the pixel intensity of T1w MR images in pFUS-targeted regions were normalized to an untreated region in the base region of the heart (n = 3/group).
To evaluate the pFUS-induced myocardial tissue permeability, Evans Blue dye (EBD) (50 mg/kg) (Sigma-Aldrich, St. Louis, MO) suspended in 1× sterilized PBS was administered intravenously prior to pFUS. Rats were euthanized and fixed as described above. EBD was detected in histological sections by fluorescence microscopy (λex = 589 nm; λem = 615 nm) using a fluorescence slide scanner (Aperio FL, Leica Biosystem Inc., Buffalo Grove, IL).
pFUS-treated myocardium (n = 5–10/time point) was harvested at 0.17, 1, 3, 6, 12, 18 and 24 h and was immediately frozen in liquid N2. Sham-treated rats (receiving pFUS with no power to the transducer) were also harvested and termed as 0 h. Samples were homogenized in cell lysis buffer containing a protease inhibitor cocktail (S8820-2TAB; Sigma-Aldrich, St. Louis, MO). The total protein content of homogenates was determined by bicinchoninic acid assay (23227; ThermoFisher Scientific, Waltham, MA). Homogenates (2 mg/mL total protein) were analyzed using a multi-plexed immuno assay for a rat cytokine/chemokine panel (RECYMAG65K27PMX; EMD Millipore, MA). The same homogenates were also analyzed by enzyme-linked immunosorbent assays (ELISA) for the following cardiac injury markers: heart-type fatty acid binding protein (H-FABP) (MBS725463; MyBioSource Inc., San Diego, CA), cardiac troponin I (cTnI) (LS-F23616; LSBio Inc., Seattle, WA), N-terminal pro b-type natriuretic peptide (NT-proBNP) (LS-F23593; LSBio Inc.), and tumor necrosis factor alpha (TNF-α) (AB46070; Abcam, Cambridge, MA) and heat shock protein 70 (HSP70) (AB133060; Abcam). All assays were performed according to manufacturers’ protocols and were read on a spectrophotometric plate reader (Spectra Max M5, Molecular Devices, Sunnyvale, CA).
For histological and fluorescent immunohistochemical (fIHC) analyses, rats were perfused with 4% PFA following euthanasia and equilibrated in 30% sucrose following overnight fixation in 4% PFA. For fIHC, frozen tissue sections (10 µm) were permeabilized with 0.1% Tween-20 in 1× PBS (TPBS) followed by antigen retrieval with Proteinase-K (Life Technologies, Frederick, MD). Sections were blocked with SuperBlock (ThermoFisher Scientific, Waltham, MA) and incubated with an appropriate primary antibody: FITC-conjugated sheep anti-albumin (10 µg/mL) (Abcam, Cambridge, MA), HIS48 (1:20 dilution) (Bio-Rad) or CD68 (10 µg/mL) (ab31630; Abcam) for 1 h at room temperature. The slides were then cover-slipped with a DAPI-containing mounting medium and imaged on a fluorescence slide.
To examine morphology, 10 µm sections of myocardium and lung tissue were stained with hematoxylin and eosin (H&E) and scanned with a bright-field slide scanner (Aperio SC2, Leica Biosystem Inc.). The fraction of pulmonary microhemorrhage in right lungs was analyzed within freehand-drawn ROIs over the total lung area using ImageJ (National Institutes of Health) (3 sections/animal, n = 3).
All data are presented as mean ± standard deviation (SD) and data analyses were performed with Prism (version 7, GraphPad Software, Inc. La Jolla, CA). One-way analysis of variance (ANOVA) with Dunnett post hoc tests was used for multiple comparisons. The level of significance was set at p < 0.05 (*p < 0.05, **p < 0.01 and ***p < 0.001).
Precise placement of the rats on the MR-guided pFUS system was necessary to orient the heart perpendicular to the ultrasonic transducer and minimize US exposure to the lungs (Fig. 1). There was approximately 40% attenuation of US intensity through the chest wall (Additional file 1: Figure S1). Treatment groups are identified by the PNP of the transducer output, however, intramyocardial PNP were estimated to be 0.6, 1.2, 1.8, 2.4, 3.6 and 4.8 MPa, for transducer outputs of 1, 2, 3, 4, 6, 8 MPa, respectively. Post-sonication MRI (FFE, TE = 5 ms, TR = 13 ms, FA = 45° and slice thickness was 2.5 mm with 3.5 s temporal resolution) revealed no injury to the right lung at PNP of 3 MPa; however, increased pulmonary signal intensity was observed at PNP ≥ 6 MPa (see Additional file 2: Figure S2).
pFUS effect on molecular and cardiac injury markers
To evaluate the molecular effects of pFUS on myocardium, rats (n = 5/group) were sonicated at various PNP (i.e., 0 = sham, 1, 3, 4, 6, 8 MPa) and euthanized 4 h post-treatment. NT-proBNP, a marker of cardiac failure, was evaluated over the range of PNP studied. When the myocardium was sonicated with PNP > 3 MPa, NT-proBNP was significantly elevated compared to sham control (p < 0.05 ANOVA) (Fig. 2b). Elevations in NT-proBNP were observed up to 6 MPa. Based on this result, subsequent experiments were performed at 6 MPa. cTnI expression was not increased following pFUS at 6 MPa (Fig. 2c). HSP70 was not elevated by pFUS at any PNP tested (Additional file 3: Figure S3).
Molecular responses to pFUS
Within 10 min post-pFUS, TNF-α and interleukin (IL)-1β were significantly elevated (p < 0.05, ANOVA), as well as chemotactic factors granulocyte colony-stimulating factor (GCSF), macrophage inflammatory protein 1 alpha (MIP-1α), monocyte chemoattractant protein-1 (MCP-1), and interferon gamma-induced protein 10 (IP-10) (p < 0.05, ANOVA) (Fig. 3). Between 1 and 6 h post-pFUS, significant (p < 0.05, ANOVA) increases in expression of IL-1α, IL-2, IL-5, interferon (IFN)-γ, epidermal growth factor (EGF), granulocyte macrophage colony-stimulating factor (GM-CSF), growth-regulated oncogene keratinocyte chemoattractant (GRO-KC) and regulated on activation, normal T cell expressed and secreted (RANTES) were observed. During this time period, significant elevations in the anti-inflammatory cytokines IL-4 and 13 were also observed (Fig. 3). The pFUS-induced expression of cytokines, chemokines, and trophic factors (CCTF) returned to sham-control levels within 24 h (Fig. 3; Additional file 4: Figure S4 for the primary data). No increases in expression of IL-6, 10, 12, 17, vascular endothelial growth factor (VEGF) or MIP-2 following sonication at 6 MPa .
Ex vivo MRI in sonicated myocardium
At 4 h post-pFUS, rats (n = 3) were perfused and hearts were harvested for ex vivo MRI studies. Each rat received an injection of gadolinium chelate prior to sonication in order to delineate changes in targeted areas in the myocardium by high resolution ex vivo MRI (Fig. 4). T1w images revealed contrast enhancement across the myocardial apex when compared to a section near the base (Fig. 4j–l) that was not present at PNPs ≤ 3 MPa (Fig. 4a–i). Compared to sham control, the enhancement was approximately 40% higher in myocardium treated at 6 MPa (Fig. 4m). Enhancement was not detectable by 24 h post-sonication (Fig. 4n). Ex vivo MRI revealed contrast enhancement located at the myocardial apex that was outside of the targeted area in the LV and septum.
H&E staining was performed on hearts harvested 4 and 24 h post-pFUS at 6 MPa and sham control. Neither red blood cell (RBC) extravasation (micro-hemorrhages) nor changes to histological architecture were observed following sonication (Fig. 5c, f). fIHC revealed the presence of albumin in extracellular spaces at the myocardial apex following sonication. Similarly, EBD fluorescence was detected in pFUS-treated myocardium (Fig. 6). The region of albumin (Additional file 5: Figure S5A–C) and EBD staining (Fig. 6) correlated to regions of contrast enhancement on the ex vivo MRI scans (Fig. 4). No considerable albumin staining was observed at 24 h post-pFUS treatment (Additional file 5: Figure S5D–F).
The lungs are in the pFUS beam path and pulmonary exposure to pFUS is unavoidable. We examined lung sections from animals that received pFUS at 1, 3 and 6 MPa. H&E staining of the right lung revealed RBC extravasation in alveolar spaces with treatments > 4 MPa (Fig. 7). The percentage area of lung parenchyma with hemorrhage following pFUS was 47% at 4 MPa, 56% at 6 MPa, and 68% at 8 MPa (Fig. 7i). At lower pFUS PNP (i.e., 1 and 3 MPa) there was minimal evidence of pulmonary damage when compared to sham control (Fig. 7; Additional file 2: Figure S2).
To evaluate the innate immune response, fIHC analyses were performed at 24 and 48 h post-sonication. At 24 h, more macrophages (CD68+ cells) and granulocytes (HIS48+ cells) were observed in the myocardial apex compared to the untreated base of the heart (Fig. 8). Infiltrating macrophages and neutrophils became undetectable at 48 h post-pFUS (Additional file 6: Figure S6).
The major findings of this study were that non-gated MRI-guided pFUS targeted to the heart over a range of PNPs resulted in myocardial edema, and a transient pattern of molecular changes similar to a sterile inflammatory response (SIR). The SIR-like response was characterized by an early increase in TNF-α expression followed by upregulation of both pro- and anti-inflammatory CCTF that returned to baseline levels of expression by 24 h. We also observed a short-lived, but significant increase in the cardiac injury marker NT-proBNP within 10 min after sonication without increases in the cardiac injury markers cTnI or H-FABP. pFUS at ≥ 4 MPa revealed myocardial edema and pulmonary hemorrhage. The transient changes to the myocardium, as well as associated pulmonary hemorrhage are consistent with models of mild chest trauma and cardiac contusion.
The main purpose of this study was to examine the molecular and histological changes following pFUS at various PNP to the myocardium. It has recently been shown in preclinical models that image-guided FUS could be used as a noninvasive tool to pace and control heart rate [20,21,22]. These studies did not evaluate the effects of pFUS on cardiac biomarkers or subsequent molecular or histological changes within the myocardium or adjacent lung [29, 30]. To target pFUS to the myocardium, MRI was performed using 1-mm-thick sections that were sufficient to encompass the area of pFUS beam. Based on EBD extravasation in the myocardium following pFUS exposure, our results indicate that pFUS effects were confined primarily to the heart. We found this to be the best optimization of spatial resolution and signal for rapid imaging. This study began by performing preliminary experiments across a range of PNP to determine appropriate intensities for sonicating the rat myocardium. We have previously reported that the mechanical effects of pFUS in skeletal muscle and kidney induced rapid (within 30 min) increase in the expression of TNF-α compared to sham control when sonications were performed at 4 MPa [15,16,17,18,19]. Thus, we chose the same FUS parameters that we have used previously for the current study. Similar to the previous study, we observed significant increases in TNF-α within 15 min post pFUS starting at PNP of 4 MPa (not corrected for attenuation) (Fig. 2a). At PNP ≥ 4 MPa, significant increases in NT-proBNP, that is associated with myocardial stretch, was observed in the absence of other injury biomarkers. In order to maximize pFUS-induced CCTF and cell adhesion molecule (CAM) expression, we used 6 MPa. Previous reports using either pFUS or unfocused US to the myocardium combined infusions of microbubbles (MB) contrast agents provided limited evaluations of the CCTF and CAM response in the parenchyma. pFUS with MB infusion targeted to the peri-infarct regions in canine myocardium showed significant increases in IL-1β, VEGF, vascular cell adhesion molecule and stromal derived factor-1alpha . Proteomic analysis following pFUS + MB infusion targeted to rat hearts resulted in significant increases in IL-1β, IL-4, IL-6, MCP-1, and TNF-α without increase in VEGF when compared to untreated control myocardium . In a hamster model of chronic cardiomyopathy, the combination of US with MB infusion showed significant increases in mRNA expression and on histology of VEGF, basic fibroblastic growth factor and CAM along with an upregulation of TNF-α, IL-1β, and MCP-1 in the myocardium 3 days after sonication . The latter study also infused bone marrow mononuclear cells following sonication and was able to demonstrate increased homing to the myocardium, along with improvements in myocardial perfusion, cardiac function, and decreased fibrosis . Taken together these studies suggest that the molecular response by the myocardium to pulsed US + MB results in a pro-inflammatory response with increased expression of TNF-α and IL-1 that could be exploited to induce an enhanced homing and retention of infused stem cells to targeted tissues [16, 17, 19].
In the current study, there were significant elevations in pro-inflammatory CCTFs including TNF-α, IFN-g, IL-1α, IL-1β, IL-2, IP-10, MIP-1α, and MCP-1 within 1 h following sonication that would be consistent with cardiac injury. The rapid increase of both IL-1α and β post-pFUS indicate cardio-myofibril injury consistent with sterile inflammation presumably through an NF-kB pathway . The increased expression of TNF-α and IL-1β and chemotactic factors (EGF, GM-CSF, RANTES, GRO-KC, GCSF, MIP-1α, MCP-1 and IP-10) following sonication has been associated with mechanical stretch and remodeling of myocardium [33,34,35,36,37,38,39]. We did observe transient early increase of NT-proBNP expression that has been associated with myocardial stretch and failure [40,41,42]; however, the biomarker did return to baseline levels during the study. There was also increased expression of EGF (a potent smooth muscle vasoconstrictor) that may have an impact on myocardial perfusion and changes in vascular permeability . pFUS-induced expression of anti-inflammatory cytokines IL-4 and IL13 could limit a local SIR. The temporal molecular changes following pFUS would be consistent with a transient SIR that we have previously shown to occur following pFUS + MB exposure in the rat brain following the opening of the blood–brain barrier . In the current study, we did not observe increased expression in VEGF and HSP70 following pFUS to the myocardium. These results were unexpected since cardiomyocytes express HSP70 under the various stress conditions and the lack of increase in VEGF was surprising since we have evidence of vascular leakage of albumin into the interstitial space [44,45,46,47,48]. Further investigation will be required to determine the myocardial response to pFUS from the basis of cellular response and stress (i.e., other types of HSP [49, 50]) and the lack of increased elevation of VEGF that is usually present following sonication to tissues [15,16,17,18,19].
There are few reports investigating cardiac injury marker responses, such as creatine kinase MB (CKMB), H-FABP, IL-6, TNF-a, cTnI and NT-proBNP from blood in cardiac contusion models [51,52,53,54,55]. Cardiac contusion models vary with respect to the distribution of the mechanical insults over the entire chest wall that may not cover the myocardium [56,57,58,59]. In the current study, MR-guided pFUS was used to target the myocardium resulting in mechanical insult to the heart and lungs. MRI examination of the rat myocardium following pFUS at > 6 MPa revealed gadolinium-chelate enhancement in the apex consistent with alteration in vascular integrity that is often observed in ischemia or contusion [60, 61]. The changes in vascular permeability with interstitial edema following pFUS has been observed in skeletal muscle [15, 62,63,64]. Histological examination of the sonicated myocardium staining did not reveal evidence of ischemia or microhemorrhages, However, immunofluorescent staining for albumin and EBD revealed extravasation into the interstitial space and an innate immune response with infiltration of neutrophils and macrophages was detected that cleared by 48 h.
The damage to the pulmonary microvasculature resulting in hemorrhage at PNP ≥ 4 MPa, and in combination with the CCTF gradient in the sonicated myocardium maybe responsible for the immune cells infiltration. There have been frequent reports that pulmonary damage is secondarily associated with blunt myocardial contusion due to the high kinetic energy transfer from the chest [59, 65,66,67,68,69]. Further investigation would be needed to understand the role of infiltrating macrophages and neutrophils in the myocardium following pFUS. Our observations suggest that amplification of the SIR by those cells could contribute to the remodeling of the transiently injured myocardium [70, 71].
There are several limitations of this study that need to be addressed. We were unable to synchronize the pFUS to cardiac and respiratory cycles due to technical limitations of the experiment that may have resulted in a greater amount of sonicated myocardium than treatment planning intended. Furthermore, the ultrasound injury to the lungs may have been avoided if it was possible to perform respiratory gating during sonication. Because of the position of the heart in the rat chest wall it was unlikely that pulmonary hemorrhage could have been avoided following sonication at any PNP. It is important to note that previous sonication studies targeting the heart did not comment on pulmonary injury presumably due to the lower PNP pressures coupled with the infusion of MB that resulted in acoustic cavitation in the myocardium [26,27,28]. We were also unable to acquire cardiac function studies to determine if pFUS altered various parameters that would be indicative of injury.
The proteomic changes following pFUS to the rat heart was consistent with a transient SIR and innate immune response in the myocardium. We also observed a transient increase in NT-proBNP that would suggest myocardial stretching. The presence of interstitial edema upon contrast enhanced MRI and microscopy would suggest some compromise to vascular integrity that resolves over 24 h. The molecular and pathologic changes associated with pulmonary hemorrhages following pFUS suggest that using US treatment as an extracorporeal cardiac pacing tool could result in unwanted consequences requiring detailed treatment planning as well as cardiac and respiratory gating of the sonication. Further evaluation of cardiac function, such as left ventricular ejection fraction and myocardial strain, would be needed to determine if pFUS treatment could be used as a development of a model of cardiac injury and chest trauma.
one-way analysis of variance
cell adhesion molecule
cytokines, chemokines, and trophic factors
creatine kinase MB
cardiac troponin I
Evans blue dye
epidermal growth factor
enzyme-linked immunosorbent assay
multislice fast field echo
granulocyte colony-stimulating factor
granulocyte macrophage colony-stimulating factor
growth-regulated oncogene keratinocyte chemoattractant
hematoxylin and eosin
heart-type fatty acid binding protein
high intensity focused ultrasound
heat shock protein 70
interferon gamma-induced protein 10
monocyte chemoattractant protein-1
macrophage inflammatory protein 1 alpha
magnetic resonance imaging
N-terminal pro b-type natriuretic peptide
phosphate buffered saline
pulsed focused ultrasound
peak negative pressure
regulated on activation, normal T cell expressed and secreted
red blood cell
region of interest
sterile inflammatory response
- TNF- α:
tumor necrosis factor alpha
Tween-20 in 1× PBS
vascular endothelial growth factor
Naghavi M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.
Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125:1043–52.
Fox CS, et al. A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol. 2005;95:856–9.
Thom T, et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–151.
Pepys MB, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006;440:1217–21.
Thompson PD, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease—a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109–16.
Chen HM, Chao YF. Change in quality of life in patients with permanent cardiac pacemakers: a six-month follow-up study. J Nurs Res. 2002;10:143–50.
Seifert H, Oltmanns D, Becker K, Wisplinghoff H, von Eiff C. Staphylococcus lugdunensis pacemaker-related infection. Emerg Infect Dis. 2005;11:1283–6.
Elias WJ, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2013;369:640–8.
Thuroff S, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003;17:673–7.
Vaezy S, et al. Treatment of uterine fibroid tumors in a nude mouse model using high-intensity focused ultrasound. Am J Obstet Gynecol. 2000;183:6–11.
Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5:321–7.
Tempany CMC, McDannold NJ, Hynynen K, Jolesz FA. Focused ultrasound surgery in oncology: overview and principles. Radiology. 2011;259:39–56.
McDannold NJ, King RL, Jolesz FA, Hynynen KH. Usefulness of MR imaging-derived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits. Radiology. 2000;216:517–23.
Burks SR, et al. Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model. PLoS ONE. 2011;6:e24730.
Tebebi PA, et al. Cyclooxygenase-2 or tumor necrosis factor-alpha inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle. Stem Cells. 2015;33:1173–86.
Burks SR, et al. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice. Stem Cells. 2015;33:1241–53.
Ziadloo A, et al. Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound. Stem Cells. 2012;30:1216–27.
Burks SR, Ziadloo A, Kim SJ, Nguyen BA, Frank JA. Noninvasive pulsed focused ultrasound allows spatiotemporal control of targeted homing for multiple stem cell types in murine skeletal muscle and the magnitude of cell homing can be increased through repeated applications. Stem Cells. 2013;31:2551–60.
Marquet F, et al. Non-invasive cardiac pacing with image-guided focused ultrasound. Sci Rep. 2016;6:36534.
Dalecki D, Keller BB, Raeman CH, Carstensen EL. Effects of pulsed ultrasound on the frog-heart. 1. Thresholds for changes in cardiac-rhythm and aortic pressure. Ultrasound Med Biol. 1993;19:385–90.
Dalecki D, Raeman CH, Carstensen EL. Effects of pulsed ultrasound on the frog-heart. 2. An investigation of heating as a potential mechanism. Ultrasound Med Biol. 1993;19:391–8.
Zheng M, Shentu W, Chen D, Sahn DJ, Zhou X. High-intensity focused ultrasound ablation of myocardium in vivo and instantaneous biological response. Echocardiography. 2014;31:1146–53.
Bessiere F, et al. Ultrasound-guided transesophageal high-intensity focused ultrasound cardiac ablation in a beating heart: a pilot feasibility study in pigs. Ultrasound Med Biol. 2016;42:1848–61.
Andrade JG, Macle L. Improving ablation strategies for the treatment of atrial fibrillation. Expert Rev Med Devices. 2014;11:77–88.
Zen K, et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol. 2006;40:799–809.
Ghanem A, et al. Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction. J Mol Cell Cardiol. 2009;47:411–8.
Zhong S, et al. Enhanced homing of mesenchymal stem cells to the ischemic myocardium by ultrasound-targeted microbubble destruction. Ultrasonics. 2012;52:281–6.
O’Brien WD, Zachary JF. Lung damage assessment from exposure to pulsed-wave ultrasound in the rabbit, mouse, and pig. IEEE Trans Ultrason Ferroelectr Freq Control. 1997;44:473–85.
Zachary JF, et al. Lesions of ultrasound-induced lung hemorrhage are not consistent with thermal injury. Ultrasound Med Biol. 2006;32:1763–70.
National Research Council. Guide for the care and use of laboratory animals. 8th ed. Washington, DC: The National Academies Press; 2011.
Karra R, Knecht AK, Kikuchi K, Poss KD. Myocardial NF-kappa B activation is essential for zebrafish heart regeneration. Proc Natl Acad Sci USA. 2015;112:13255–60.
Palmieri EA, et al. Differential expression of TNF-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium. Am J Physiol Heart Circ Physiol. 2002;282:H926–34.
Honsho S, et al. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Circ Res. 2009;105:1149–58.
Takano H, et al. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med. 2006;84:185–93.
Berk BC, et al. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Investig. 1985;75:1083–6.
Maekawa Y, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2004;44:1510–20.
Bachmaier K, Toya S, Malik AB. Therapeutic administration of the chemokine CXCL1/KC abrogates autoimmune inflammatory heart disease. PLoS ONE. 2014;9:e89647.
Aukrust P, et al. Elevated circulating levels of C–C chemokines in patients with congestive heart failure. Circulation. 1998;97:1136–43.
Panagopoulou V, et al. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem. 2013;13:82–94.
Hall C. NT-ProBNP: the mechanism behind the marker. J Cardiac Fail. 2005;11:S81–3.
Uusimaa P, et al. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol. 2004;97:251–6.
Kovacs ZI, et al. Disrupting the blood–brain barrier by focused ultrasound induces sterile inflammation. Proc Natl Acad Sci USA. 2017;114:E75–84.
Meng XZ, Brown JM, Ao LH, Banerjee A, Harken AH. Norepinephrine induces cardiac heat shock protein 70 and delayed cardioprotection in the rat through alpha(1) adrenoceptors. Cardiovasc Res. 1996;32:374–83.
Meng XZ, Harken AH. The interaction between HSP70 and TNF-alpha expression: a novel mechanism for protection of the myocardium against post-injury depression. Shock. 2002;17:345–53.
Currie RW, Karmazyn M, Kloc M, Mailer K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ Res. 1988;63:543–9.
Knowlton AA, Brecher P, Apstein CS. Rapid expression of heat-shock protein in the rabbit after brief cardiac ischemia. J Clin Investig. 1991;87:139–47.
Howard G, Geoghegan TE. Altered cardiac tissue gene-expression during acute hypoxic exposure. Mol Cell Biochem. 1986;69:155–60.
Schafler AE, et al. The expression of heat shock protein 60 in myocardium of patients with chronic atrial fibrillation. Basic Res Cardiol. 2002;97:258–61.
Lin KM, et al. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation. 2001;103:1787–92.
Adams JE 3rd, et al. Improved detection of cardiac contusion with cardiac troponin I. Am Heart J. 1996;131:308–12.
Dogan H, et al. N-terminal pro-B-type natriuretic peptide as a marker of blunt cardiac contusion in trauma. Int J Clin Exp Pathol. 2015;8:6786–92.
Rajan GP, Zellweger R. Cardiac troponin I as a predictor of arrhythmia and ventricular dysfunction in trauma patients with myocardial contusion. J Trauma. 2004;57:801–8.
Kinugawa T, et al. Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure. Int J Cardiol. 2003;87:83–90.
Sirera R, et al. Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels. Eur J Heart Fail. 2003;5:27–31.
Pandian NG, Skorton DJ, Doty DB, Kerber RE. Immediate diagnosis of acute myocardial contusion by two-dimensional echocardiography: studies in a canine model of blunt chest trauma. J Am Coll Cardiol. 1983;2:488–96.
Moomey CB, Fabian TC, Croce MA, Melton SM, Proctor KG. Cardiopulmonary function after pulmonary contusion and partial liquid ventilation. J Trauma. 1998;45:283–90.
Davis KA, Fabian TC, Ragsdale DN, Trenthem LL, Proctor KG. Endogenous adenosine and secondary injury after chest trauma. J Trauma. 2000;49:892–8.
Wang ND, Stevens MH, Doty DB, Hammond EH. Blunt chest trauma: an experimental model for heart and lung contusion. J Trauma. 2003;54:744–8.
Waldenstrom A, Martinussen HJ, Gerdin B, Hallgren R. Accumulation of hyaluronan and tissue edema in experimental myocardial-infarction. J Clin Investig. 1991;88:1622–8.
Vago H, et al. Cardiac contusion in a professional soccer player visualization of acute and late pathological changes in the myocardium with magnetic resonance imaging. Circulation. 2010;121:2456–61.
Friden J, Sfakianos PN, Hargens AR, Akeson WH. Residual muscular swelling after repetitive eccentric contractions. J Orthop Res. 1988;6:493–8.
Baker BA, et al. Quantitative histology and MGF gene expression in rats following SSC exercise in vivo. Med Sci Sports Exerc. 2006;38:463–71.
Geronilla KB, et al. Dynamic force responses of skeletal muscle during stretch-shortening cycles. Eur J Appl Physiol. 2003;90:144–53.
Bachurska-Yovcheva S, Novakov I, Staykov D, Delev D. Evaluation of the histological changes in an experimental model of cardiopulmonary contusion. Virchows Arch. 2014;465:S282–S282.
Raghavendran K, et al. A rat model for isolated bilateral lung contusion from blunt chest trauma. Anesth Analg. 2005;101:1482–9.
Cohn SM. Pulmonary contusion: review of the clinical entity. J Trauma. 1997;42:973–9.
Cohn SM, DuBose JJ. Pulmonary contusion: an update on recent advances in clinical management. World J Surg. 2010;34:1959–70.
Balci AE, et al. Blunt thoracic trauma in children: review of 137 cases. Eur J Cardiothorac Surg. 2004;26:387–92.
Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159–73.
Horckmans M, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017;38:187–97.
KWJ and JAF designed the study; KWJ, TW and BL performed the experiments; KWJ, TW, SRB and JAF analyzed and interpreted the data. KWJ, SRB, and JAF drafted the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Availability of data and materials
The datasets used and analyzed in the current study are available from the corresponding author on request and clearance by the National Institutes of Health.
Consent for publication
Ethics approval and consent to participate
All animal studies were approved by the Animal Care and Use Committee at the NIH Clinical Center, and experiments were performed in accordance with the National Research Council’s Guide for the Care and Use of Laboratory.
This work was supported by the Intramural Research Programs of the Clinical Center and the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1: Figure S1. pFUS attenuation by the rat chest walls. pFUS intensity was attenuated approximately 40% by the rat chest wall.
Additional file 2: Figure S2. MRI of lungs pre- and post-pFUS. There were no changes in MR contrast in lungs of sham-treated rats (A and B) or rats treated at 3 MPa (C and D). (E and F) There were notable changes in signal intensity following pFUS exposure at 6 MPa. Scale bar = 10 mm.
Additional file 3: Figure S3. HSP70 expression following pFUS exposure. HSP70 expression was unchanged compared to sham controls following pFUS exposure at any PNP (n = 4–5).
Additional file 4: Figure S4. Time course of CCTF and cardiac markers. Quantitation of CCTF and cardiac markers after pFUS treatment. The y-axes represent picograms of cytokines per milligram of myocardium; the x-axes represent time [h] post-pFUS. Asterisks represent statistical significance of p < 0.05 based on ANOVA.
Additional file 5: Figure S5. Albumin staining. (A) fIHC revealed that greater amounts of albumin in pFUS-targeted regions after 4 h. Higher magnifications of (B) untreated and (C) treated regions. (D) Albumin staining 24 h post-pFUS showed no differences between pFUS-treated and untreated regions. Higher magnifications of (E) untreated and (F) treated regions. Blue/Green colors represent DAPI/Albumin respectively. Scale bar = 6 mm in A and D. Scale bar = 100 µm in B, C, E, and F.
Additional file 6: Figure S6. fIHC of macrophage and granulocyte infiltration into pFUS-targeted myocardium 48 h post-pFUS. (A and B) HIS48 staining showed no differences between treated and untreated regions. (C and D) CD68 staining showed no differences between treated and untreated regions. Scale bar = 100 µm.
About this article
Cite this article
Jang, K.W., Tu, TW., Nagle, M.E. et al. Molecular and histological effects of MR-guided pulsed focused ultrasound to the rat heart. J Transl Med 15, 252 (2017). https://doi.org/10.1186/s12967-017-1361-y
- Focused ultrasound
- Sterile inflammation
- Lung trauma
- Cardiac contusion